Found: 32
Select item for more details and to access through your institution.
Targeted next-generation sequencing of DNA regions proximal to a conserved GXGXXG signaling motif enables systematic discovery of tyrosine kinase fusions in cancer.
- Published in:
- Nucleic Acids Research, 2010, v. 38, n. 20, p. 6985, doi. 10.1093/nar/gkq579
- By:
- Publication type:
- Article
Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22057-8
- By:
- Publication type:
- Article
Anchored multiplex PCR for targeted next-generation sequencing.
- Published in:
- Nature Medicine, 2014, v. 20, n. 12, p. 1479, doi. 10.1038/nm.3729
- By:
- Publication type:
- Article
Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors.
- Published in:
- Nature Genetics, 2013, v. 45, n. 2, p. 131, doi. 10.1038/ng.2522
- By:
- Publication type:
- Article
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 3, p. 493, doi. 10.1007/s10637-023-01371-6
- By:
- Publication type:
- Article
Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 6, p. 601, doi. 10.1016/j.cllc.2021.06.006
- By:
- Publication type:
- Article
Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in <i>U2AF1</i> Reveals Commonly Altered Splicing Events.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087361
- By:
- Publication type:
- Article
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 154, n. 1, p. 155, doi. 10.1007/s10549-015-3592-z
- By:
- Publication type:
- Article
Meningioma transcription factors link cell lineage with systemic metabolic cues.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 10, p. 1331, doi. 10.1093/neuonc/noy057
- By:
- Publication type:
- Article
Longitudinal Circulating Tumor DNA Modeling to Predict Disease Progression in First‐Line Mutant Epidermal Growth Factor Receptor Non‐Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 2, p. 349, doi. 10.1002/cpt.3113
- By:
- Publication type:
- Article
The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 4, p. 881, doi. 10.1002/ijc.29825
- By:
- Publication type:
- Article
Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 90, p. 1, doi. 10.1126/scitranslmed.3002356
- By:
- Publication type:
- Article
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.
- Published in:
- Journal of Translational Medicine, 2016, v. 14, p. 1, doi. 10.1186/s12967-016-1075-6
- By:
- Publication type:
- Article
Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 10, p. 606, doi. 10.1002/gcc.22272
- By:
- Publication type:
- Article
Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm.
- Published in:
- Genes, Chromosomes & Cancer, 2012, v. 51, n. 1, p. 54, doi. 10.1002/gcc.20930
- By:
- Publication type:
- Article
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-015-0160-2
- By:
- Publication type:
- Article
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 4, p. 517, doi. 10.1007/s11523-023-00965-7
- By:
- Publication type:
- Article
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma.
- Published in:
- Oncology, 2016, v. 90, n. 6, p. 339, doi. 10.1159/000445978
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 684, doi. 10.1634/theoncologist.2016-0030
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-ResponsiveALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 762, doi. 10.1634/theoncologist.2015-0497
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
- Published in:
- Oncologist, 2016, v. 21, n. 1, p. 33, doi. 10.1634/theoncologist.2015-0241
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
- Published in:
- Oncologist, 2015, v. 20, n. 10, p. 1132, doi. 10.1634/theoncologist.2015-0156
- By:
- Publication type:
- Article
Prospective Comprehensive Genomic Profiling of Advanced Gastric Carcinoma Cases Reveals Frequent Clinically Relevant Genomic Alterations and New Routes for Targeted Therapies.
- Published in:
- Oncologist, 2015, v. 20, n. 5, p. 499, doi. 10.1634/theoncologist.2014-0378
- By:
- Publication type:
- Article
OncogenicAlterations in ERBB2/HER2Represent Potential Therapeutic Targets Across Tumors From Diverse Anatomic Sites of Origin.
- Published in:
- Oncologist, 2015, v. 20, n. 1, p. 7, doi. 10.1634/theoncologist.2014-0234
- By:
- Publication type:
- Article
A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 3561, doi. 10.2147/OTT.S90766
- By:
- Publication type:
- Article
Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas.
- Published in:
- PLoS Medicine, 2007, v. 4, n. 10, p. e294, doi. 10.1371/journal.pmed.0040294
- By:
- Publication type:
- Article
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
- Published in:
- Genome Medicine, 2017, v. 9, p. 1, doi. 10.1186/s13073-017-0424-2
- By:
- Publication type:
- Article
Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
- Published in:
- Genome Medicine, 2017, v. 9, p. 1, doi. 10.1186/s13073-017-0408-2
- By:
- Publication type:
- Article
Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0176181
- By:
- Publication type:
- Article